Hafsah Tariq, Abdul Samad, Saadullah Jan, Hafiz Muhammad Mazhar Asjad, Jawad Akbar Khan, Farah Sabeen Bugti, Muhammad Naeem, Abdul Rahim Bugti, Adnan Ayoub
{"title":"Molecular characterization of extensively drug-resistant Salmonella serovar Typhi in patients with gastrointestinal complications in Quetta, Pakistan.","authors":"Hafsah Tariq, Abdul Samad, Saadullah Jan, Hafiz Muhammad Mazhar Asjad, Jawad Akbar Khan, Farah Sabeen Bugti, Muhammad Naeem, Abdul Rahim Bugti, Adnan Ayoub","doi":"10.36721/PJPS.2025.38.4.REG.14048.1","DOIUrl":null,"url":null,"abstract":"<p><p>Extensive drug resistance (XDR) S. typhi have been evaluated in patients with gastrointestinal disturbance who attended multiple tertiary care hospitals in Quetta, Balochistan, Pakistan. Blood samples of total of 480 patients were obtained and S. typhi was isolated and verified by PCR. Isolates were subjected to antimicrobial susceptibility testing and antimicrobial resistance (AMR) genes of 1<sup>st</sup>, 2<sup>nd</sup> line antibiotics, 3<sup>rd</sup> generation cephalosporin and azithromycin were identified by PCR. Among 65 PCR confirmed S. typhi cases, 18(27%) were Multidrug resistance (MDR), 25(38%) XDR, 13 (20%) Extended spectrum β-lactamase (ESBL) and only 4(6%) Azithromycin-resistant XDR S. typhi. The high frequency was observed for the antibiotics-resistant genes catA1, bla<sub>TEM-1</sub> (100%), dhfr7 (95%), sul1 (98%), gyrA, gyrB, parC (93%) and qnrS and parE 100% each. The frequency of bla<sub>CTX-M-15</sub> and acrB were 78% and 6% respectively. We found high burden of MDR, XDR and ESBLs S. typhi. The AMR genes were similar to those of the regional countries. Azithromycin resistance was low could be a drug of choice against XDR S. typhi in the study area. The study provided the molecular profile of AMR S. typhi in Quetta, capital of Balochistan province of Pakistan.</p>","PeriodicalId":19971,"journal":{"name":"Pakistan journal of pharmaceutical sciences","volume":"38 4","pages":"1354-1367"},"PeriodicalIF":0.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan journal of pharmaceutical sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36721/PJPS.2025.38.4.REG.14048.1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Extensive drug resistance (XDR) S. typhi have been evaluated in patients with gastrointestinal disturbance who attended multiple tertiary care hospitals in Quetta, Balochistan, Pakistan. Blood samples of total of 480 patients were obtained and S. typhi was isolated and verified by PCR. Isolates were subjected to antimicrobial susceptibility testing and antimicrobial resistance (AMR) genes of 1st, 2nd line antibiotics, 3rd generation cephalosporin and azithromycin were identified by PCR. Among 65 PCR confirmed S. typhi cases, 18(27%) were Multidrug resistance (MDR), 25(38%) XDR, 13 (20%) Extended spectrum β-lactamase (ESBL) and only 4(6%) Azithromycin-resistant XDR S. typhi. The high frequency was observed for the antibiotics-resistant genes catA1, blaTEM-1 (100%), dhfr7 (95%), sul1 (98%), gyrA, gyrB, parC (93%) and qnrS and parE 100% each. The frequency of blaCTX-M-15 and acrB were 78% and 6% respectively. We found high burden of MDR, XDR and ESBLs S. typhi. The AMR genes were similar to those of the regional countries. Azithromycin resistance was low could be a drug of choice against XDR S. typhi in the study area. The study provided the molecular profile of AMR S. typhi in Quetta, capital of Balochistan province of Pakistan.
期刊介绍:
Pakistan Journal of Pharmaceutical Sciences (PJPS) is a peer reviewed multi-disciplinary pharmaceutical sciences journal. The PJPS had its origin in 1988 from the Faculty of Pharmacy, University of Karachi as a biannual journal, frequency converted as quarterly in 2005, and now PJPS is being published as bi-monthly from January 2013.
PJPS covers Biological, Pharmaceutical and Medicinal Research (Drug Delivery, Pharmacy Management, Molecular Biology, Biochemical, Pharmacology, Pharmacokinetics, Phytochemical, Bio-analytical, Therapeutics, Biotechnology and research on nano particles.